Ilumya and Infections
Result of checking the interaction of drug Ilumya and disease Infections for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The use of tildrakizumab may increase the risk of infection. Treatment with tildrakizumab should not be started in patients with active infection until the infection resolves or is adequately treated. Consider the risks and benefits prior to using this agent in patients with chronic infection or a history of recurrent infection. It is recommended to monitor the patient closely and consider discontinuation of tildrakizumab if a patient develops a clinically important or serious infection or is not responding to standard therapy.
Ilumya - infekcje 
Ilumya - infecções 
Ilumya - jangkitan 
Ilumya - infeksi 
Ilumya - infezioni 
Ilumya - infections 
Ilumya - Infektionen 
Ilumya - infecciones 
Ilumya - инфекции 
Ilumya - enfeksiyonlar 
Ilumya - الالتهابات 
Ilumya - 感染